Premium
TREATMENT AND OUTCOMES OF PATIENTS WITH NK/T‐CELL LYMPHOMA TREATED WITH MODIFIED (m)SMILE AND INTENSITY‐MODULATED RADIOTHERAPY (IMRT), A SINGLE CENTER EXPERIENCE
Author(s) -
Ghione P.,
Qi S.,
Imber B.S.,
Venkatraman S.,
Moskowitz A.,
Galasso N.,
Lunning M.,
Straus D.,
Sauter C.,
Dahi P.,
Dogan A.,
Yahalom J.,
Horwitz S.M.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.156_2631
Subject(s) - medicine , single center , etoposide , ifosfamide , regimen , radiation therapy , chemotherapy , t cell lymphoma , stage (stratigraphy) , lymphoma , anthracycline , asparaginase , oncology , cancer , surgery , gastroenterology , breast cancer , leukemia , paleontology , lymphoblastic leukemia , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom